NGF, a trophic polypeptide, is necessary for the normal development and survival of certain populations of neurons in the CNS and PNS. In the CNS, cholinergic neurons of the basal forebrain magnocellular complex (BFMC) are prominent targets of NGF. During rat development, NGF increases the activity of ChAT in these neurons. In adult rats with experimental injury of axons in the fimbria-fornix, NGF prevents degenerative changes in axotomized cholinergic BFMC neurons in the medial septal nucleus (MSN). Because the amino acid sequences of NGF and its receptor (NGF-R) are highly conserved across species, we hypothesized that mouse NGF would also prevent degeneration of cholinergic BFMC neurons in nonhuman primates. Therefore, the present study was designed to test whether fimbria-fornix lesions result in retrograde degenerative changes in basal forebrain cholinergic neurons in macaques, whether these changes are prevented by mouse NGF, and whether the protective effect of NGF is selective for cholinergic neurons of the basal forebrain.
Following unilateral complete transection of the fornix, animals were allowed to survive for 2 weeks, during which time half of the subjects received intraventricular NGF in vehicle and the other half received vehicle alone. In animals receiving vehicle alone, there was a 55% reduction in the number of ChAT-immunoreactive cell bodies within the MSN ipsilateral to the lesion; loss of immunoreactive somata was more severe in caudal planes of the MSN. Remaining immunoreactive neurons appeared smaller than those in control, unoperated animals. In Nissl stains, there was no apparent loss of basophilic profiles in the MSN, but cells showed reduced size and intensity of basophilia.
Treatment with NGF almost completely prevented reductions in the number and size of cholinergic neurons and had a significant general effect in preventing atrophy in basophilic magnocellular neurons of the MSN, though some basophilic neurons in the MSN did not appear to respond to NGF. Adjacent 7-pm-thick sections stained with ChAT and NGF-R immunocytochemistry revealed that these markers are strictly colocalized in individual neurons in the MSN in controls and in both groups of experimental animals. Thus, mouse NGF profoundly influences the process of axotomyinduced retrograde degeneration in cholinergic BFMC neurons in primates. The in vivo effectiveness of mouse NGF on primate BFMC neurons suggests that mouse or human recombinant NGF may be useful in ameliorating the AChdependent, age-associated memory impairments that occur in nonhuman primates. Such experiments will prove essential for the design of strategies for use of tropic factors in human diseases associated with degeneration of basal forebrain cholinergic neurons.
In the CNS and PNS, certain populations of neurons are dependent for their normal development and survival on NGF, a 13-kDa peptide (Korsching et al., 1985; Thoenen et al., 1987; Whittemore and Seiger, 1987; Mobley et al., 1989) . Projection targets of these neurons express NGF mRNA and protein (Korsching et al., 1985; Shelton and Reichardt, 1986; AyerLeLievre et al., 1988) . At target fields, NGF is taken up by highaffinity NGF receptors (NGF-R) on nerve terminals (Greene and Shooter, 1980; Taniuchi et al., 1986; Stach and Perez-Polo, 1987) and the complex of NGF with its receptor is transported retrogradely to neuronal cell bodies (Seiler and Schwab, 1984; Johnson et al., 1987) where it has a number of actions, including apparent enhancement of cell viability . In the CNS, cholinergic neurons of the basal forebrain magnocellular complex (BFMC) are the main targets of NGF. During development, NGF increases levels of ChAT activity in rat BFMC neurons (Gnahn et al., 1983; Hefti et al., 1985; Mobley et al., 1986; Gahwiler et al., 1987; Johnston et al., 1987; Martinez et al., 1987 ) and the expression of a variety of genes, including those coding for the prion protein and the amyloid precursor protein (Mobley et al., 1988) . In adult rats with fimbria-fornix lesions, NGF treatment prevents the axotomy-induced degenerative changes that occur in BFMC cells (Hefti, 1986; Williams et al., 1986; Kromer, 1987; Gage et al., 1988; Rosenberg et al., 1988; Whittemore et al., 1989 ).
To date, there has been no direct examination of the actions of NGF in nonhuman primates. However, several indirect lines of evidence suggest that BFMC neurons of primates are capable of responding to NGF. The amino acid sequence of NGF, including 1 hydrophilic domain around residue 33 (glycine) implicated in the binding of NGF to its receptor, is highly conserved across species (Angeletti and Bradshaw, 197 1; Dunbar et al., 1984; Meier et al., 1986) . NGF-R, also highly conserved , is expressed in BFMC neurons of primates Schatteman et al., 1988) . Because of the conservation of NGF and NGF-R, it is likely that mouse NGF can act upon primate neurons that express NGF-R. Consistent with this prediction is the preliminary observation that developing neurons of the human dorsal root ganglia respond to mouse NGF (Caviedes and Rapoport, 1988) . To test the potential for NGF to ameliorate the effects of BFMC cell injury in primates, we used a well-established, simple model: transection of axons of BFMC neurons in the septohippocampal pathway. These axons originate in cholinergic and other neurons of the medial septal nucleus (MSN) and nucleus of the diagonal band of Broca (DBB) and course to hippocampal targets predominantly in the fomix (Swanson and Cowan, 1979 ), a dorsally coursing discrete bundle that is easily accessible to experimental manipulations (Fig. 1A) . In the rat, following transection of the fomix, neurons of the MSN show reductions in cell size, decrements in cholinergic markers (AChE histochemical activity and ChAT immunoreactivity), and alterations in elements of the neuronal cytoskeleton (Daitz and Powell, 1954; McLardy, 1955; Sofroniew et al., 1983 Sofroniew et al., , 1987 Pearson et al., 1984; Gage et al., 1986; Hefti, 1986; Armstrong et al., 1987; Koliatsos et al., 1989a) . Eventually, there is evidence of cell loss Arrnstronget al., 1987; Applegate et al., 1989; Koliatsos et al., 1989a; O'Brien et al., 1990; Tuszynski et al., 1990) . The present study demonstrates that similar events occur in macaque monkeys following transection of BFMC axons in the fomix, and that mouse NGF prevents the axotomy-induced degenerative changes induced in these cholinergic BFMC neurons.
Preliminary data from this study have been presented in abstract form (Koliatsos et al., 1989b) .
Materials and Methods
Surgery. Cynomolgus monkeys (Macaca fascicularis; n = 10; weight, 3-7 kg) were used as subjects in this study. Seven animals were anesthetized with halothane, intubated, and artificially ventilated, 3 animals served as unoperated controls. To facilitate brain relaxation and minimize retraction pressure, mannitol(20%) was infused systemically over 30 min (2 gm/kg, iv.) prior to craniotomy; subsequently, mannitol was replaced with normal saline at a continuous, slow intravenous drip throughout surgery. Under sterile conditions, the dura was exposed through a lo-mm trephine hole drilled 10-20 mm anterior to the interaural line. The sagittal sinus was retracted and the 2 hemispheres separated. The body of the fomix was visualized through a lateral callosotomy 13-14 mm anterior to the interaural line (Szabo and Cowan, 1984) approximately 5 mm caudal to the MSN, fomical fibers on the right.halfof the body of the fomix were transected at the coronal plane with an arachnoid knife. The lesion was completed with a coronal (Tlike) extension of the callosomy to the midline. Immediately following the lesion, a 12-mm ventricular access device (Model 44100, Connell Neurosurgical, Exton, PA), appropriately modified for the monkey brain, was introduced transcortically or via the callosotomy window into the lateral ventricle and secured in place with sutures passing through the pericranium (Fig. l&C') . To confirm stable placement of the ventricular access device within the ventricle, metrizamide (0.5 ml) was infused into the reservoir, and a digital ventriculogram was obtained. All animals recovered without complications.
NGF administration. Mouse NGF was prepared by ion-exchange chromatography and characterized by gel electrophoresis and by a chick dorsal root ganglion bioassay as described previously (Mobley et al., 1986) . Prior to use, NGF was passed through a 0.2~pm filter (Uniflo, Schleicher and Schuell, Keene, NH) and stored at 200 &ml in 0.2% acetic acid at -70°C. NGF was lyophilized and resuspended in acidified cerebrospinal fluid (CSF, see below) immediately prior to the intraventricular injection.
Following surgery, NGF dissolved in vehicle (n = 3), or vehicle alone (n = 3) was injected immediately and then every second day under aseptic conditions into the Silastic reservoir of the ventricular access device (625 ILR per iniection for a total of 8 iniections, resulting in a total dose of 5 mg). qehicle consisted of roughly 300.~1 acetic-acidacidified artificial CSF. DH 7.0 Iin mM: NaCl. 122.6: NaHCO,. 26.2: KCl, 5.4; MgSO,, 2.0; NaH,PO,: 1.2; CaCl,, 2:O; glucose, 10.0 (Cole et al., 1989) ]. Following delivery of NGF, the ventricular access device was further washed with an additional 300 ~1 of artificial CSF in order to insure that NGF was not retained within the components of the ventricular access device. Cytochrome C was not used as a control drug, because, in a preliminary case, we found that it caused reactive astrocytosis, primarily in circumventricular brain regions. In all animals, small samples of CSF were withdrawn from the reservoir before each NGF application, and levels of NGF in the CSF were determined in a 2-site enzyme-linked immunoabsorbent assay (ELISA) performed as described (Weskamp and Otten, 1987; Mobley et al., 1989) .
Histology and immunocytochemistry. Two weeks after the onset of treatment, monkeys were perfused via the aorta with 2-3 liters PBS (pH, 7.4) followed by roughly 6 liters 3% freshly depolymerized paraformaldehyde (duration of perfusion-fixation, 25 min). Unoperated animals were prepared in the same way. Brains were blocked stereotaxically, and blocks were rinsed and cryoprotected in 20% sucrose in 0.1 M phosphate buffer (pH, 7.4) for at least 24 hr. Sections through the septal region were cut at the transverse plane on a cryostat and processed in series for Cresvl violet (40 tirn); Cresvl violet (10 urn): ChAT immunocytochemistry (40 pm), using the monoclonalantibody AB8 (Levey et al., 1983) according to published protocols (Koliatsos et al., 1989a) ; NGF-R immunocytochemistry (40 rm), using the monoclonal antibody NGFRS (Marano et al., 1987) ; and immunocytochemistry for phosphorylated neurofilaments (40 Km), using antibodies 6-17 and 7-05 (Koliatsos et al., 1989a) . For NGF-R immunocytochemistry, sections were pretreated in 0.4% Triton X-100 (TX) in Tris-buffered saline (TBS) for 30 min, then in 5% normal goat serum in TBS including 0.1% TX for 1 hr. Sections were then incubated sequentially in the primary antibody diluted 1:80,000 (48 hr) and, after 3 rinses (10 min each) in TBS, in affinity-purified goat anti-mouse IgG (1: 100, 1 hr). Both antibodies were diluted in TBS including 2% normal aoat serum and 0.1% TX. Sections were rinsed again and-placed in mon&lonal mouse peroxidaseantiperoxidase diluted 1:200 in the same diluent as the primary and secondary antibody but without TX. All previous incubations and rinses were performed at 4°C. After the peroxidase-antiperoxidase step, sections were rinsed again and taken for a standard diaminobenzidine chromagen reaction. To characterize the lesion, sections through the fomix were stained with Cresyl violet and with immunocytochemistry for the phosphorylated neurofilament epitope 6-17. Sections through the hippocampus were processed for ChAT immunocytochemistry or AChE histochemistry using a silver intensification of the Tsuji reaction (Tsuji, 1974) .
In selected animals from all 3 groups, pairs of adjacent 7-pm-thick sections (200 pm apart; on average, 10 pairs per monkey brain) were processed for NGF-R and ChAT immunocytochemistry on slides. Procedures were essentially the same as with the floating sections, with the following exceptions: incubations were done at room temperature, concentrations of primary antibodies were 1:25 for ChAT and 1: 1000 for NGF-R, the concentration of linking antibody (goat anti-mouse) was 1: 20, and the concentration of mouse peroxidase-antiperoxidase was 1: 100. The purpose of this dual immunocytochemical protocol was to examine the degree of concomitant expression of ChAT and NGF-R immunoreactivity in single neurons of the MSN under normal conditions and following axotomy with or without NGF treatment.
Morphometry and statistics. Numbers and sizes of ChAT-immunoreactive or Nissl-stained perikarya of the MSN on lesioned and unlesioned sides, as well as from 3 normal, unlesioned controls, were quantified using a computerized image analysis system &oats Associates, Westminster, MD). A total of 4 pairs of sections, 300 pm apart and representing standard transverse planes (Fig. 2) , were analyzed from each case. Adjacent Nissl-(1 O-pm) and ChAT-stained (40~pm) sections were used for quantitation. In ChAT preparations, all obvious perikaryal cholinergic profiles within the MSN were selected for analysis. In Nisslstained sections, a rectangular frame was placed over the MSN on both sides with its longitudinal axis corresponding to the midline. The same A, The anatomy of the septohippocampal system and fornix in the monkey is depicted. The lesion was placed in the body of the fomix (arrow). The number at the top of the arrow represents the distance (in mm) from the interaural line. B, A lateral callosotomy permits access to the right half of the body of the fornix (panel I), which is subsequently transected at the coronal plane together with perforating fornical branches in the corpus callosum (panel 2, shaded area). Subsequently, the cannula of the vehicular access device is implanted in the ipsilateral lateral ventricle through the window of the callosotomy (panel 3). C, Three-dimensional rendering of the callosotomy-for&al lesion; see text and B, panels I and 2.
area (in pm2), representing half of the rectangle and covering most of edge-detection program. Particular effort was made to eliminate ChATthe nucleus, was scanned bilaterally (Fig. 2~ ). This strategy was chosen immunoreactive swollen fiber fragments (present only in the caudal to eliminate inconsistencies in sampling neurons in lateral sectors of MSN in lesioned animals) from analysis. the MSN, which can be easily confused with cells of the lateral septum For statistical analysis, the numbers of neurons ipsilateral to the lesion in conditions associated with atrophy of cells in the MSN. In all cases, were expressed as percentages of numbers of nerve cells on the unleneurons were outlined, and the area was calculated using an automatic sioned side. Counts were corrected for differences in cell size by applying Abercrombie's adjustment for split-cell error (Abercrombie, 1946) . This correction was chosen after considering several more recent stereological methods that are more appropriately applied to less complex systems (Gundersen et al., 1988a,b) . Mean neuronal area was calculated independently and compared to neuronal area at the corresponding level in control, unlesioned animals. For neuronal number, a repeated-measured analysis of variance (ANOVA: BMDP 2V oroaram) was aDDl i ed with --I __ surgical procedure (lesion/vehicle or lesion/NGF) as the main factor and level of section as the repeated measure. Duncan's multiple range test was used for post hoc analysis of group differences.
To calculate the percentage of dual-labeled (ChAT and NGF-R) profiles in the MSN in representative cases of vehicle-and NGF-treated animals and controls, initial maps of ChAT-and NGF-R-immunoreactive profiles of the MSN in adjacent sections were generated with the aid of a neuroanatomical mapping system (software provided by Dr. Mark E. Molliver. The Johns Hookins Universitv School of Medicine); 5 (7-rm-thick)' pairs of sections were used per animal. Subsequently, mapped ChAT-immunostained sections were superimposed on corresponding adjacent sections stained for NGF-R by overlaying the respective glass slides and carefully matching outlines of sections under the microscope. Sections were studied under 20 x magnification. Using visual clues provided by vessels and spatial arrangement of cell groups, dual-labeled cells were identified and marked on maos of cholinergic and NGF-R-containing neurons generated from the same sections. Dual-labeled neurons were expressed as percentages of the total number of ChAT-and NGF-R-immunoreactive MSN neurons from all 5 pairs of sections analyzed per animal.
Results

Evaluation of NGF treatment
In CSF samples collected from NGF-treated animals throughout the period of treatment, NGF was detected at CSF concentrations ranging from 2 to 150 &ml. In pretreatment samples, the concentration of NGF was below level of detectability by the assay (100 rig/ml). Samples taken at the end of the treatment period tended to have higher concentrations of NGF. NGF concentration was roughly proportional to the length of treatment. Because the ventricular access devices were cleared with CSF at the end of each individual treatment, the upward trend in NGF concentration suggested that NGF levels within the ventricular system increased over time, though the rate and degree of CSF clearance might have been variable.
Eficacy of the lesion
In all monkeys, there was a profound reduction in levels of AChE histochemical activity and ChAT immunoreactivity in all hippocampal sectors ipsilateral to the lesion throughout the anteroposterior extent of the hippocampal formation (Fig. 3) . The prosubiculum showed moderate levels of AChE and ChAT, but, as reported elsewhere (Kitt et al., 1987) , this region is innervated, besides the fornix, by a ventral pathway originating in the nucleus basalis and coursing in the ansa peduncularis; this pathway was not damaged by our manipulations. Our immunocytochemical and histochemical preparations of the hippocampus confirmed the efficacy of the transections, and tissues from all these subjects were taken for quantitative analysis of retrograde changes in neurons of the MSN.
Retrograde changes in the MSN
The septohippocampal system is topographically organized along both the mediolateral and the rostrocaudal axes, with MSN neurons utilizing the fomix exclusively for their hippocampal projections, whereas neurons in the nucleus of the DBB partially project through ventral routes (Swanson, 1976; Kitt et al., 1987; Koliatsos et al., 1988) . Therefore, following lesions of the fomix, we focused on retrograde changes in the MSN and effects of NGF on these cholinergic neurons of the BFMC. duced to roughly 55% of neurons in the contralateral MSN. MSN. Based on Nissl stains, there was no apparent loss of Remaining immunoreactive neurons were, on average, smaller neurons on the lesioned side. In fact, morphometric analysis than cholinergic MSN neurons from control animals (Figs. 4, showed a statistically insignificant trend towards increased num-6). In Nissl stains, MSN neurons on the lesioned side showed bers of neurons. Because the calculated increase in basophilic reduced basophilia and a 10% reduction in size (Figs. 5, 7) . All profiles on the lesioned side (-10%) was equal to the average of these abnormalities were more severe in caudal planes of the cell shrinkage on the same side, this unexpected difference was considered to be caused by reduction in the total area of the ration of the retrograde changes described above. No significant MSN on the lesioned side. Some magnocellular MSN neurons reductions were noted in the number of ChAT-and NGF-Rcontralateral to the lesion also showed evidence of mild atrophy.
immunoreactive perikarya on the side of the axotomy. These In monkeys treated with NGF, there was a dramatic ameliocells had a normal shape, and their size was, on average, 30% greater than the size of MSN neurons from control, unlesioned side: one subpopulation, apparently responsive to NGF, exhibanimals (Figs. 4, 6) . In Nissl stains, cell sizes were, on average, ited normal size and shape; the other subpopulation showed 5% less than the sizes of MSN neurons from nonlesioned, unreduced size and basophilia and altered shape (Figs. 5x 8) . The treated animals (Figs. 5, 7) . The study of Nissl-stained sections effect of NGF was generally more pronounced in caudal than revealed 2 subpopulations of basophilic profiles on the lesioned in rostral MSN levels, perhaps related to the proximity of the site of infusion and a higher local concentration of NGF. Remarkable hypertrophy of cholinergic MSN neurons was noted contralateral to the lesion. On the contralateral side, ChATpositive cells were, on average, 5 5% larger than MSN cholinergic neurons from control, unoperated animals (Fig. 4b,f) , whereas basophilic profiles on the same side did not show any difference when compared to Nissl-stained profiles in control animals ( Fig.   Sb,d,f) .
The study of adjacent 7-pm-thick sections stained for ChAT or NGF-R indicated that 95% of the ChAT-immunoreactive cell bodies in the MSN of control, lesioned/untreated, and lesioned/NGF-treated animals also expressed NGF-R immunoreactivity. There were no NGF-R-immunoreactive cells outside the population of the cholinergic MSN neurons in any of the groups of animals, either on the lesioned side or on the side contralateral to the lesion (Fig. 9 ).
Sections stained with antibodies for phosphorylated neurofilament epitopes did not show any aberrant (perikaryal) immunoreactivity in the MSN or nucleus of the DBB of any of the control or lesioned/vehicle-treated animals. However, both antibodies 6-17 and 7-05 stained a few magnocellular neurons, located mostly in rostra1 planes of the MSN in lesioned/NGFtreated animals (Fig. 10 ).
Discussion
Our results indicate that mouse NGF has significant biological effects on primate CNS neurons in vivo and can effectively prevent the progressive degenerative changes that occur in BFMC cholinergic neurons following transection of their axons in the fornix. The significance of the NGF effect on primate neurons is 3-fold: heterologous (mouse) NGF is effective on BFMC neurons in primates, the same patterns of NGF-mediated trophic influences appear to exist in species with a much more complex forebrain than the rat, and similar NGF therapy may have benefits for animal and human disorders that show degeneration of cholinergic cells of the BFMC.
The septohippocampal system-a term mainly used in the literature dealing with rodents-is a component of the basal forebrain-telencephalic projection that originates predominantly from neurons in the MSN and projects primarily via the fornix to hippocampus (Swanson et al., 1987) . In the monkey, the system is organized in a similar fashion: axons arise from neurons of the BFMC, situated mostly in the MSN and nucleus of DBB, and project via the fornix and the fimbria to hippocampal targets (Fig. 1A) . Approximately 30% of these neurons are cholinergic, whereas the majority of other cells presumably contain GABA (Koliatsos et al., 1988) . In the rat, BFMC axons can reach the hippocampus by routes outside the fimbria-fornix, including the dorsal fornix (Wyss et al., 1980) , the cingulate bundle/supracallosal striae (Swanson and Cowan, 1979; Mimer et al., 1983) , and a less well-defined ventral pathway, containing roughly 10% of septohippocampal axons (Gage et al., 1984; Milner and Amaral, 1984) . In primates, as in rats, there is a ventral pathway, but the majority of these fibers originate in the nucleus basalis and nucleus of the DBB, rather than the MSN (Kitt et al., 1987; Koliatsos et al., 1988) . Dorsal pathways outside the fomix do not contribute significantly to the cholinergic innervation of hippocampus in the monkey (Rosene and Van Hoesen, 1987) ; the monkey does not have a distinct dorsal fomix (Rosene and Van Hoesen, 1977) , and it is unlikely that the supracallosal striae, sometimes termed the dorsal fomix et al. l NGF Prevents Degeneration i n Monkey Basal Forebrain Figure IO . In lesioned/NGF-treated animals, some MSN perikarya contain phosphorylated neurofilaments. Both perikarya depicted in this illustration belong to the anterior MSN. One MSN neuron is stained with antibody 6-17 (a), and the other MSN cell reacts with the neurofilament antibody 7-05 (b). In b, note intense immunoreactivity in a dendrite and perikaryodendritic junction (arrows). Scale bar, 20 pm. (McLardy, 1955; Poletti and Creswell, 1977) contain significant numbers of efferent and afferent hippocampal fibers (Rosene and Van Hoesen, 1987) . The only other dorsal contribution to choline& innervation of the hippocampus is made by the callosal perforating fibers (Rosene and Van Hoesen, 1987) . Our lesion transected both the fornix and the overlying corpus callosum at the coronal plane. The cingulate bundle and associated fibers were not damaged, as this would result in a large (and unnecessary) midline lesion of the cortex.
The design and time course of our present experiment does not clearly distinguish between 2 possible effects of NGF: prevention of cell death and restoration of the normal phenotype of injured neurons. Indeed, as indicated by our cell counts in Nissl-stained sections, there is no evidence of cell death in the monkey MSN 2 weeks following transection of the fomix. Our studies of the fimbria-fomix axotomy model in the rat indicate that cell death in the MSN becomes prominent between 3 and 4 weeks postaxotomy (Applegate et al., 1989; see also O'Brien et al., 1990; Tuszynski et al., 1990) . Similar evidence is provided indirectly by other studies that show significant "retrieval" of ChAT-immunoreactive cell bodies in the MSN after delayed NGF treatment of rats with fimbria-fomix transections (Hagg et al., 1988) . Although MSN neurons do not die within the survival time used in our present study, these cells do show altered phenotypes, including reductions in size and transmitterassociated enzymes, as well as alterations in elements of the cytoskeleton, that is, perikaryal phosphorylation of neurofilaments. Similar alterations have been described in rats Hefti, 1986; Armstrong et al., 1987; Koliatsos et al., 1989a) . Because these abnormalities precede the death of BFMC cells, amelioration by NGF of some of these effects indirectly suggests that NGF can prevent cell death. It should be noted that perikaryal phosphorylated neurofilaments were not prominent in the perikarya of MSN and the nucleus of the DBB in our lesioned/vehicle-treated monkeys. This does not mean that cytoskeletal abnormalities of this type do not occur in axotomized BFMC neurons in primates. As reported in our previous studies in rats (Koliatsos et al., 1989a) , the appearance of phosphorylated neurofilaments in perikarya is an early response to axotomy, which, by day 15 following the lesion, may have been considerably attenuated in the monkey. Because the disappearance of phosphorylated neurofilaments in cell bodies following axotomy is very likely associated with cell death (Klosen and van den Bosch de Aguilar, 1987; Koliatsos et al., 1989a) , the persistence of this cytoskeletal abnormality in some axotomized MSN neurons in monkeys treated with NGF is an additional indication that NGF delays retrograde degenerative changes that precede cell death. However, the hypothesis that NGF acts to prevent cell death must be tested more directly by NGF treatment of animals with fimbria-fomix lesions for prolonged periods of time (4 weeks), that is, the period within which 50% of axotomized MSN cells have degenerated Applegate et al., 1989) .
The magnitude of the effect of NGF on cholinergic neurons of the monkey BFMC was similar to that in rats treated with the same preparation of NGF using ventricular access devices (V. E. Koliatsos, W. C. Mobley, and D. L. Price, unpublished observations). This finding indicates that mouse NGF is potent across species and suggests that NGF domains important for receptor binding and activation (Angeletti and Bradshaw, 197 1; Dunbar et al., 1984; Meier et al., 1986 ) may be conserved in mice and primates. Based on the average size of surviving basophilic profiles, the magnitude of the effect of NGF is smaller than that based on size (and number) of ChAT-immunostained perikarya. This reduced effect is probably due to the fact that Nissl stains reveal 2 subpopulations of basophilic profiles on the lesioned side of NGF-treated animals, one showing signs of responsiveness to NGF, and the other with reduced size and abnormal shape. This discordance was also noted in rats treated with NGF using the same procedures (Koliatsos, Mobley, and Price, unpublished observations) and suggests that noncholinergic neurons of the BFMC may not respond to NGF as do cholinergic neurons. This differential responsiveness to NGF is further supported by our findings on adjacent 7-pm-thick sections stained with ChAT and NGF-R showing strict colocalization of ChAT and NGF-R immunoreactivity in MSN neurons on both the lesioned and the unlesioned sides in control The Journal of Neuroscience, December 1990, 70(12) 3811 animals and in both experimental groups. Although nerve cells that respond to NGF are bound to express NGF-R, it is conceivable that low levels of NGF-R expression may prevent immunocytochemical detection of all NGF-R-containing neurons. However, in view of the fact that NGF upregulates the expression of NGF-R in cholinergic neurons of the BFMC (Higgins et al., 1989) , the correspondence of ChAT and NGF-R immunoreactivity, especially in the NGF-treated group of animals, suggests strongly that only choline& MSN neurons bear the NGF-R and respond to NGF.
As discussed above, the majority of noncholinergic cells of the MSN and nucleus of the DBB contain GABA. GABAergic cells comprise at least 30% of the BFMC cells projecting to the hippocampus (Kijhler et al., 1984) , and their axons selectively contact inhibitory intemeurons in the hippocampus (Freund and Antal, 1988) . The magnitude and target specificity of this inhibitory component of the septohippocampal projection suggest that GABAergic septal neurons have a major functional significance in this system (Freund and Antal, 1988) . There is disagreement as to whether GABAergic neurons of the BFMC, identified with immunocytochemistry for GABA or glutamic acid decarboxylase, have NGF-R and respond to NGF. Although Dreyfus and co-workers (Dreyfus et al., 1989) have indicated that these nerve cells bear the NGF-R in vitro, in vivo studies did not show septal GABAergic neurons to respond to NGF . Definitive conclusions on patterns of retrograde degeneration and effects of NGF on GABAergic septal neurons, especially in the monkey, may require in situ hybridization histochemistry for glutamic acid decarboxylase transcripts (Walker et al., 1989) .
NGF treatment of animals with lesions of the septohippocampal system may partially restore innervation of deafferented terminal fields (Haroutunian et al., 1986) and may, at least transiently, ameliorate behavioral deficits related to hippocampal denervation . Moreover, NGF has been reported to have effects on age-associated deficits in behaviors dependent on the septohippocampal circuit (Fischer et al., 1987) , perhaps by ameliorating degenerative age-related alterations that occur in BFMC neurons. A beneficial effect of NGF on behavior suggests its use in future experiments involving aged, memory-impaired monkeys (Bartus et al., 1979 (Bartus et al., , 1980 Davis, 1985; Presty et al., 1987; Phelps et al., 1989a,b; Bachevalier et al., 1991) . This view is further supported by the fact that NGF can upregulate the expression of NGF-R (Higgins et al., 1989) , a phenomenon that could serve to enhance further the responsiveness of injured cells to the exogenously supplied trophic factor. If NGF proves effective and nontoxic when chronically administered to nonhuman primates, all of the conditions (Phelps et al., 1989a,b) will have been met for consideration of a carefully designed trial of NGF therapy in individuals with Alzheimer's disease, a disorder in which there is consistent degeneration of BFMC cholinergic neurons (Bowen et al., 1976; Perry et al., 1977 Perry et al., , 1982 Davies, 1979; Whitehouse et al., 1982; Arendt et al., 1983; Francis et al., 1985; Price, 1986) .
